Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Clinical Trial Phase 1 Vaccine TB/FLU-01L by Intranasal and Sublingual Application for Specific Immunotherapy Pulmonary Tuberculosis

NCT03017378 is registered in ClinicalTrials.gov with Research Institute for Biological Safety Problems as lead sponsor.

NCT NCT03017378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03017378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Clinical Trial Phase 1 Vaccine TB/FLU-01L by Intranasal and Sublingual Application for Specific Immunotherapy Pulmonary Tuberculosis
Lead sponsor
Research Institute for Biological Safety Problems
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2013
Completion date
February 28, 2015
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis